Samsung Bioepis

Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone.

Launch date

1938

Employees

Market cap

Enterprise valuation

Incheon South Korea (HQ)

Revenues, earnings & profits over time

KRW	2022
Revenues	232.8b

Date	Investors	Amount	Round
-	Samsung BioLogics	N/A	-
Jun 2018	Biogen	KRW748.6b	Early VC
Total Funding		€571m

Tech stackLearn more about the technologies and tools that this company uses.

Financials